NEUROPATHIX, INC

From the company

Subsidiary Kannalife Sciences, Inc. Awarded Study Grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) Learn More Kannalife awarded $1.49M grant from MJFF 1/5 > < Subsidiary Kannalife Sciences, Inc. Awarded Phase 2 Study Grant from National Institute of Neurological Disorders and Stroke (NINDS) as part of the NIH HEAL Initiative Learn More Kannalife awarded $2.97M grant from NIH 2/5 > < We’re a Biopharmaceutical Company Engineering Breakthough Therapeutics Targeted for the Treatment of Inflammation, Neurodegeneration, Oxidative Stress and Neuropathic Pain Related Diseases. About Neuropathix Neuropathix, Inc. Therapeutics Targeting Inflammation 3/5 > < We’re Deploying the Most Creative and Innovative Scientific Minds to Discover and Bring to Market Patented Novel Therapeutics for Patients with Serious Unmet Medical Needs. Learn More The Science of Neuropathix™ 4/5 > <.